Previous close | 15.20 |
Open | 7.65 |
Bid | 5.80 |
Ask | 6.00 |
Strike | 250.00 |
Expiry date | 2024-06-21 |
Day's range | 5.60 - 7.65 |
Contract range | N/A |
Volume | |
Open interest | 820 |
While Danaher (DHR) surpasses first-quarter earnings and revenue estimates, its performance is hurt by a decrease in core sales in the Biotechnology segment.
The medical company reports first-quarter adjusted earnings of $1.92 a share, beating Wall Street estimates of $1.72.
Although the revenue and EPS for Danaher (DHR) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.